Michael Taphorn v. Union Pacific Railroad Co.

District Court, D. Nebraska·Decided May 4, 2026·No. 8:23-cv-00339·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEBRASKA

MICHAEL TAPHORN,

Plaintiff, 8:23CV339

v. MEMORANDUM UNION PACIFIC RAILROAD CO., AND ORDER

Defendant.

This matter is before the Court on defendant Union Pacific Railroad Co.’s (“Union Pacific”) Motion to Strike (Filing No. 74) plaintiff Michael Taphorn’s (“Taphorn”) Rule 26(a)(2) retained expert report of Jason B. Garlie, M.D. (“Dr. Garlie”) (Filing No. 67-15). See Fed. R. Civ P. 37(c). In that vein, Union Pacific also asks the Court to strike Taphorn’s brief in opposition to summary judgment (Filing No. 64) and statement of additional facts (Filing No. 65), which both rely on Dr. Garlie’s opinions. For the reasons set forth below, the Court will strike those documents. I. BACKGROUND Taphorn began his career with Union Pacific in 1980. After he had a cardiac pacemaker implanted in 2019, Union Pacific placed permanent work restrictions on him which ultimately resulted in his removal from service. He then sued Union Pacific under the Americans with Disabilities Act of 1990 (“ADA”), 42 U.S.C. §§ 12101 and 12112(b)(6) on August 4, 2023, alleging Union Pacific discriminated against him because of his disability and used its fitness-for-duty procedure (“FFD”) to “screen out” individuals with disabilities like him. Fast forward a year into the litigation, and on August 30, 2024, Taphorn disclosed two retained experts, Kevin L. Trangle, M.D. (“Dr. Trangle”), an occupational-medicine doctor, and Melissa Snelson, an economist—along with two of his treating providers as non-retained experts. By an amended case progression order entered on September 30, 2024 (Filing No. 31), the Court set October 18, 2024, as the deadline for Union Pacific to disclose its own experts, and gave Taphorn until November 15, 2024, to disclose any rebuttal experts. Abiding by that timeline, Union Pacific disclosed John Holland, M.D. (“Dr. Holland”) and Brian D. Lowes, M.D. (“Dr. Lowes”) as non-retained experts (Filing No. 76-3). Discovery then progressed to depositions. Union Pacific deposed Dr. Trangle on March 12, 2025 (Filing No. 76-4). Taphorn deposed Dr. Holland on March 28, 2025, and Dr. Lowes on May 2, 2025 (Filing No. 76-4). When told the parties needed more time to complete depositions (Filing No. 45), the Court pushed the discovery deadline to August 4, 2025 (Filing No. 46). Then came the surprise leading to this discovery dispute. On July 30, 2025—just a few days before discovery was set to wrap up—Taphorn produced a new expert, Dr. Garlie, along with a supplemental report. For the first time, Taphorn explained in an email to Union Pacific’s counsel that he needed a rebuttal expert to counter what Dr. Holland and Dr. Lowes had said in their depositions (Filing No. 78-1). Specifically, Taphorn’s counsel complained that when asked about the likelihood of Taphorn’s pacemaker failing, Dr. Holland and Dr. Lowes had both estimated “somewhere between 1- and 2-percent per year.” In Taphorn’s view, Union Pacific’s October-2024 expert disclosures were deficient because they failed to summarize the facts and opinions its experts intended to offer, including the “1-2%” opinion. See Christensen v. Union Pac. R.R., No. 8:23CV268, 2025 WL 1192408, at *3 (D. Neb. Apr. 24, 2025) (noting that while non-retained experts need not provide a written report of their opinions, Rule 26(a)(2)(C) “requires disclosure of the pertinent facts and opinions to which the expert will testify,” rather than just a “general identification” of the topic). And because he thought Union Pacific’s Rule 26 disclosures from 2024 were “deficient” and omitted the “1-2%” failure rate, he argues he only had two choices: (1) move to exclude the testimony about a “1-2%” failure rate or (2) go find a new “rebuttal” expert (Filing No. 78-1). He chose the latter. He then offered to allow Union Pacific to join him in asking the Court to once again extend the “case deadlines” so that Union Pacific could depose Dr. Garlie. If Union Pacific didn’t like that option and preferred to move for sanctions under Rule 37, he suggested the parties first participate in a discovery conference with the magistrate judge. At the telephonic conference that followed (Filing Nos. 50, 72, 79), Union Pacific told a different story. From its perspective, Taphorn had been aware of Dr. Holland’s and Dr. Lowes’s “1-2%” responses since their depositions were taken in March and May but had said nothing until the end of July. And apart from the “1-2%” responses, Dr. Holland’s and Dr. Lowes’s opinions on the risk of pacemaker failure were summarized in a detailed FFD memorandum. That memorandum has been in Taphorn’s possession since May 2019 because it was given to him to as part of his FFD evaluation. It was also disclosed to Taphorn’s counsel on March 29, 2024 (Filing No. 78-4). As for the “1-2%” opinion that supposedly necessitated a brand-new expert witness, Union Pacific pointed out that Taphorn’s counsel elicited that opinion during the depositions. Union Pacific stated it did not intend to offer any particular percentage at summary judgment or trial. And Taphorn’s own expert, Dr. Trangle, had already weighed in on the issue, calling pacemaker failure “exceedingly unlikely.” In short, there was nothing for Taphorn to “rebut” and certainly no need for a new expert to do it. Taphorn’s counsel seemingly agreed that any gaps in Union Pacific’s Rule 26(a)(2) disclosures are “harmless”—provided Union Pacific does not offer the “1-2%” figures— because Taphorn has had the FFD memorandum summarizing the experts’ opinions since at least 2024 (Filing No. 79). He further explained that had Dr. Holland and Dr. Lowes limited their responses to characterizing the likelihood of pacemaker failure as an “unacceptable risk,” then he would have had “no basis to hire a rebuttal expert” (Filing No. 79).1 But because they answered his questions about failure rate with a percentage, as he sees it, that kicked open the door for him to hire a new “rebuttal” expert at the eleventh hour (Filing No. 79). Taphorn contends bringing in this new expert witness “just resets the status quo.” Once Taphorn stated he would have had “no basis to hire a rebuttal expert” without those percentages and Union promised not to use them, that should have been the end of this. As the magistrate judge patiently explained to Taphorn’s counsel, “the status quo is on [Union Pacific’s side.]” If Union Pacific is “not going to be putting on any testimony about percentage” then “there’s no need for rebuttal experts” and “we’re good to move forward with dispositive motion practice.”2 Undeterred by the magistrate judge’s sage advice, Taphorn’s counsel explained that because he had already “hired” Dr. Garlie and “paid him a substantial amount of money” he “want[s] to use his opinion regardless of whether Union Pacific offers the 1 to 2 percent opinion” (Filing No. 79). This candid admission undermines any notion that Dr. Garlie is a true “rebuttal” witness. The magistrate judge ended the teleconference by denying Taphorn’s “implied motion to extend the rebuttal expert disclosure deadline” and issued clear guidance: if Union Pacific does not offer the “1-2%” opinion at summary judgment, then Taphorn has no justification to offer Dr. Garlie’s “rebuttal” opinions. Doing so, the magistrate judge cautioned, would not be substantially justified or harmless. See Vanderberg v. Petco Animal Supplies Stores, Inc., 906 F.3d 698, 703 (8th Cir. 2018).

1During the call, counsel conceded, “Had those one to two percent opinions not been given in their depositions . . . I would not have ever hired Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Michael Taphorn v. Union Pacific Railroad Co., (D. Neb. 2026).

Michael Taphorn v. Union Pacific Railroad Co. (Michael Taphorn v. Union Pacific Railroad Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related